Institut de Recerca Sant Pau - Centre CERCA
Researchers from the Sant Pau Research Institute (IR Sant Pau) have conducted a clinical trial demonstrating that the combination of two widely available drugs, carvedilol and simvastatin, significantly improves the control of portal hypertension in patients with hepatic cirrhosis.
The third mission of La Aventura de la Mariona took place today at Tibidabo Amusement Park, with high participation from children and a day filled with science, play, and discovery. This activity offered workshops and interactive spaces dedicated to the respiratory system, bringing children closer to understanding how the apparatus that allows us to breathe works through hands-on experiences and playful activities.
BASE4 BIOSCIENCES S.L. is the new spin-off of the Sant Pau Research Institute (IR Sant Pau), created to promote translational research and the application of precision biology in the field of women’s health. The initiative is led by Dr. José Manuel Soria, head of the Genomics of Complex Diseases Research Group at IR Sant Pau, and Dr. Ángel Martínez, genetic analysis expert and member of the same group, together with Pol Cervera, a specialist in technological development. The three are founding members of the new company.
The Journal of the American Medical Association (JAMA) has recently published the updated version of the Sequential Organ Failure Assessment (SOFA), the global reference system in intensive care medicine used to assess the degree of organ dysfunction in critically ill patients. The results were also presented in parallel at the Annual Congress of the European Society of Intensive Care Medicine (ESICM LIVES 2025), held in Munich, in a featured session on current topics broadcast live.
The Francesc Cambó Hall at Sant Pau was filled with people and laughter during ImproCiencia: Aging with a Sense of Humor, an event that brought together biomedical research and improvisational theater to address key questions about health and aging in a lively and engaging way.
